Datavault AI Receives Notice of Nasdaq Trading Suspension; Common Stock Eligible to Trade on OTC Markets

Datavault AI is moving from Nasdaq to OTC due to failing the $1.00 bid minimum.

What the company is saying

Datavault AI Inc. informs investors that its common stock will begin trading on the OTC Markets at the open on November 17, 2026. The company frames this as a direct result of Nasdaq's decision to suspend trading in its shares, also effective November 17, 2026. The only reason cited for this suspension is non-compliance with Nasdaq's $1.00 minimum bid price requirement. The announcement is strictly factual, providing the precise date for both the Nasdaq suspension and the OTC Markets transition. No executives are quoted, and there is no commentary on future plans, remediation efforts, or business performance. The tone is neutral, with no attempt to downplay or embellish the regulatory action.

What the data suggests

The only quantitative figure disclosed is Nasdaq's $1.00 minimum bid price requirement, which Datavault AI failed to meet. Both the suspension from Nasdaq and the start of OTC trading are scheduled for November 17, 2026, making the transition immediate and certain. There is no information on the company's actual share price, financial performance, or operational status. The lack of additional data means investors cannot assess the company's financial health or prospects from this announcement alone. The disclosure is complete regarding the regulatory process but omits any discussion of underlying business fundamentals or corrective actions.

Analysis

The announcement is a factual disclosure regarding Datavault AI Inc.'s transition from Nasdaq to OTC Markets due to non-compliance with the $1.00 minimum bid price requirement. The language is neutral and does not attempt to frame the development positively or negatively. Only one claim is forward-looking: the company's expectation that its stock will be eligible to trade on OTC Markets as of November 17, 2026. This is a near-certain, procedural outcome rather than an aspirational projection. No financial, operational, or strategic benefits are claimed, and there is no mention of capital outlay or future plans. The gap between narrative and evidence is nonexistent; all statements are supported by disclosed dates and regulatory facts. There is no attempt to inflate the significance of the event.

Risk flags

• ●Delisting from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement signals a deterioration in market confidence and may reduce liquidity and visibility for the stock. This can make it harder for investors to buy or sell shares at favorable prices.
• ●Transitioning to OTC Markets typically results in less stringent reporting requirements and lower investor scrutiny, which can increase the risk of limited transparency and reduced access to capital. The announcement does not address any plans to regain compliance or relist on a major exchange.
• ●The absence of any financial, operational, or strategic commentary leaves investors without insight into the company's underlying business health or management's response to the delisting, increasing uncertainty about future prospects.

Bottom line

Datavault AI Inc. will be suspended from Nasdaq and begin trading on OTC Markets on November 17, 2026, solely because it failed to maintain the $1.00 minimum bid price. This move is a negative signal for liquidity, investor access, and perceived credibility, as OTC trading is generally less favorable than a major exchange listing. The announcement provides no information on the company's financials, operations, or plans to address the underlying issues that led to delisting. Investors have no basis from this disclosure to assess whether management has a strategy to recover or improve the situation. The most important takeaway is that the company is being forced off a major exchange with no accompanying plan or explanation beyond the procedural facts.

Announcement summary

(OTC:DVLT) Datavault AI Inc. announced that the Company expects its common stock will be eligible to trade on the over-the-counter market (OTC Markets) effective with the open of the market on November 17, 2026. The move to OTC Markets follows Nasdaq’s decision to suspend trading in the Company’s common stock effective November 17, 2026. Nasdaq’s decision is due to the Company’s non-compliance with Nasdaq’s $1.00 minimum bid price requirement. The Company’s common stock will transition from Nasdaq to OTC Markets as a result of this suspension. The Company has disclosed the specific date of November 17, 2026, for both the suspension on Nasdaq and the commencement of trading on OTC Markets. The $1.00 minimum bid price requirement is explicitly cited as the reason for Nasdaq’s suspension of trading. No other financial or operational figures are disclosed in this announcement. No named executives or additional counterparties are mentioned in the source text. No project, asset, or product names are referenced beyond the Company’s common stock. No license, permit, or court-case identifiers are provided. No additional material dates, deadlines, or docket numbers are stated. No further commentary or forward-looking statements are included beyond the expectation of OTC Markets eligibility.

Disagree with this article?